Subtopic Deep Dive
Differentiated Thyroid Cancer Radioiodine Therapy
Research Guide
What is Differentiated Thyroid Cancer Radioiodine Therapy?
Differentiated Thyroid Cancer Radioiodine Therapy uses 131I for remnant ablation, adjuvant therapy, and dosimetry-optimized treatment to improve recurrence-free survival.
This subtopic covers 131I dosimetry protocols, stunning prevention, and long-term outcomes in differentiated thyroid cancers. Key methods include 124I PET-based dosimetry (Jentzen et al., 2008, 153 citations) and renal clearance-adjusted dosing (Howard et al., 2017, 5 citations). Over 10 papers from 1987-2023 address optimization, with foundational work on parathyroid effects (Glazebrook, 1987, 33 citations).
Why It Matters
Optimized 131I therapy reduces recurrence in differentiated thyroid cancer patients by personalizing dosimetry, minimizing toxicity to bone marrow and lungs (Jentzen et al., 2008; Howard et al., 2017). It guides adjuvant dosing post-surgery, improving survival while addressing renal impairment risks. Real-world impact includes safer high-dose regimens for high-risk cases, as shown in practical calculators (Howard et al., 2017) and PET protocols enabling reliable lesion dosimetry estimates from 24h and 96h scans (Jentzen et al., 2008).
Key Research Challenges
Variable iodine kinetics
Highly variable lesion dosimetry requires multiple PET scans at 24h and 96h for reliable estimates (Jentzen et al., 2008). Single scans insufficient due to kinetic variability. Impacts therapy planning accuracy.
Renal clearance estimation
Renal impairment complicates 131I dosing, risking marrow toxicity without adjusted clearance models (Howard et al., 2017). Web-based calculators use modified Benua-Leeper methods for optimization. Essential for safe high-dose therapy.
Parathyroid function risk
Decicurie 131I doses affect parathyroid function, requiring monitoring in therapy protocols (Glazebrook, 1987). Balances ablation efficacy against endocrine side effects. Long-term outcomes need assessment.
Essential Papers
Optimized <sup>124</sup>I PET Dosimetry Protocol for Radioiodine Therapy of Differentiated Thyroid Cancer
Walter Jentzen, Lutz S. Freudenberg, E. G. Eising et al. · 2008 · Journal of Nuclear Medicine · 153 citations
Lesion classification into LDpA groups was feasible using a single PET scan at approximately 24 h. Because of the highly variable kinetics, 1 additional measurement at approximately 96 h was needed...
Effect of decicurie doses of radioactive iodine 131 on parathyroid function
George A. Glazebrook · 1987 · The American Journal of Surgery · 33 citations
Thyroid cancer risk after radiation exposure in adults—systematic review and meta-analysis
Nafiseh Beygom Mirkatouli, Seiko Hirota, Shinji Yoshinaga · 2023 · Journal of Radiation Research · 11 citations
Abstract Notably, the growing use of radionuclear technology, especially in diagnostic and therapeutic procedures involving radiation exposure, raises concerns about the health effects of radiation...
Clinical potential of microbiota in thyroid cancer therapy
Zilan Xie, Jiating Zhou, Xuan Zhang et al. · 2023 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 7 citations
A practical method of I-131 thyroid cancer therapy dose optimization using estimated effective renal clearance
Brandon A. Howard, Olga James, Jennifer M. Perkins et al. · 2017 · SAGE Open Medical Case Reports · 5 citations
In thyroid cancer patients with renal impairment or other complicating factors, it is important to maximize I-131 therapy efficacy while minimizing bone marrow and lung damage. We developed a web-b...
Dose Characteristics of Radiation-Induced (I-131) Thyroid Cancer
Stojarov AN · 2021 · Biomedical Journal of Scientific & Technical Research · 1 citations
Stojarov AN1* and Khrustalev VV2 Author Affiliations 1Department of Radiation Medicine and Ecology, Belarusian State Medical University, Minsk, Belarus 2Department of General Chemistry, Belarusian ...
Удосконалені методи діагностики, прогнозування та корекції ендокринопатій (раку щитоподібної залози та цукрового діабету)
М.D. Тronko, H.V. Zelinska, Galyna Zamotayeva et al. · 2023 · Endokrynologia · 1 citations
У статті узагальнено та проаналізовано матеріал, присвячений комплексному науковому дослідженню цитологічних, ультразвукових, імунологічних і кардіологічних аспектів папілярного раку щитоподібної з...
Reading Guide
Foundational Papers
Start with Jentzen et al. (2008, 153 citations) for PET dosimetry protocol establishing 24h/96h scans; Glazebrook (1987, 33 citations) for parathyroid risks from 131I doses.
Recent Advances
Study Howard et al. (2017, 5 citations) for renal clearance optimization; Piron et al. (2020) for benign disease dosimetry methods applicable to cancer.
Core Methods
Core techniques: 124I PET for lesion dosimetry (Jentzen et al., 2008), modified Benua-Leeper renal models (Howard et al., 2017), pre-therapy I-123 scans (Cassano et al., 2018).
How PapersFlow Helps You Research Differentiated Thyroid Cancer Radioiodine Therapy
Discover & Search
Research Agent uses searchPapers and exaSearch to find dosimetry papers like 'Optimized 124I PET Dosimetry Protocol' (Jentzen et al., 2008), then citationGraph reveals 153 citing works on kinetics, and findSimilarPapers uncovers renal models (Howard et al., 2017).
Analyze & Verify
Analysis Agent applies readPaperContent to extract Jentzen et al. (2008) scan timings, verifies kinetics claims with verifyResponse (CoVe), and runs PythonAnalysis for dosimetry simulations using NumPy/pandas on clearance data from Howard et al. (2017); GRADE grading scores evidence strength for protocols.
Synthesize & Write
Synthesis Agent detects gaps in stunning prevention across papers, flags contradictions in renal dosing; Writing Agent uses latexEditText, latexSyncCitations for therapy protocol drafts, latexCompile for figures, exportMermaid for dosimetry flowcharts.
Use Cases
"Model 131I renal clearance for thyroid cancer patient with GFR 45 mL/min"
Research Agent → searchPapers(Howard 2017) → Analysis Agent → readPaperContent → runPythonAnalysis(pandas GFR simulation) → outputs customized dose calculator CSV.
"Draft LaTeX review on 124I PET dosimetry protocols"
Synthesis Agent → gap detection(Jentzen 2008) → Writing Agent → latexEditText(protocol sections) → latexSyncCitations(10 papers) → latexCompile → outputs compiled PDF.
"Find open-source code for I-131 dosimetry from papers"
Research Agent → paperExtractUrls(Jentzen-like papers) → Code Discovery → paperFindGithubRepo → githubRepoInspect → outputs verified dosimetry Python repos.
Automated Workflows
Deep Research workflow scans 50+ papers via searchPapers on '131I dosimetry thyroid', structures reports with GRADE-scored sections on ablation outcomes. DeepScan's 7-step chain analyzes Jentzen et al. (2008) kinetics with CoVe checkpoints and Python verification. Theorizer generates hypotheses on microbiota-therapy interactions from Xie et al. (2023).
Frequently Asked Questions
What defines Differentiated Thyroid Cancer Radioiodine Therapy?
It involves 131I for remnant ablation, adjuvant therapy, and personalized dosimetry in differentiated thyroid cancers to optimize survival and minimize toxicity.
What are key methods in 131I dosimetry?
Methods include 124I PET scans at 24h/96h for lesion dosimetry (Jentzen et al., 2008) and effective renal clearance calculators (Howard et al., 2017).
What are major papers?
Foundational: Jentzen et al. (2008, 153 citations) on PET dosimetry; Glazebrook (1987, 33 citations) on parathyroid effects. Recent: Howard et al. (2017, 5 citations) on renal optimization.
What open problems exist?
Challenges include standardizing multi-scan protocols for variable kinetics (Jentzen et al., 2008), safer dosing in renal impairment (Howard et al., 2017), and long-term parathyroid risks (Glazebrook, 1987).
Research Thyroid Cancer Diagnosis and Treatment with AI
PapersFlow provides specialized AI tools for your field researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
AI Academic Writing
Write research papers with AI assistance and LaTeX support
Start Researching Differentiated Thyroid Cancer Radioiodine Therapy with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.